Results 241 to 250 of about 100,658 (276)
Some of the next articles are maybe not open access.

Thrombotic Microangiopathy in Cancer

Seminars in Thrombosis and Hemostasis, 2018
AbstractThrombotic microangiopathy (TMA) is a rare but often devastating complication of cancer and cancer treatment. The syndrome is defined by thrombocytopenia (i.e., a platelet count of < 150,000/mcL or > 30% decrease from baseline), microangiopathic hemolytic anemia, and some evidence of organ damage.
openaire   +3 more sources

[Thrombotic microangiopathy].

Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2023
In the emergency room, patients with anemia and thrombocytopenia are common. Although these findings can often be explained by the medical situation, thrombotic microangiopathy is an important differential diagnosis. In this case, occlusion of the smallest vessels consequently leads to functional impairment of the affected organs.
Tilman, Schmidt, Tobias B, Huber
openaire   +1 more source

[Thrombotic microangiopathy].

Der Internist, 2013
Thrombotic microangiopathy should be suspected every time the combination of microangiopathic hemolytic anemia without a coexisting cause, thrombocytopenia as well as renal and/or neurologic abnormalities occurs. The general term thrombotic microangiopathy includes different subtypes of the disease leading to abnormalities in multiple organ systems by ...
Ganser, A., Kielstein, J. T., Beutel, G.
openaire   +2 more sources

[Thrombotic microangiopathy].

Der nephrologe
Thrombotic microangiopathy (TMA) is characterized by an endothelium injury-associated formation of platelet clots in arterial and venous microvessels. Concomitant ischemia causes severe organ dysfunction and can be acutely life threatening. The underlying etiology of TMA shows a very heterogeneous disease spectrum.
Anja, Gäckler, Oliver, Witzke
openaire   +3 more sources

[Thrombotic Microangiopathies].

Deutsche medizinische Wochenschrift (1946), 2018
Thrombotic microangiopathies are almost devastating diseases leading to death at high frequency if untreated. They consist of at least five distinct entities, TTP, HUS, aHUS, TMA due to drug interference, systemic disease or post therapy TMA. Around 10 years ago there was only one established therapeutic approach as plasmapheresis. Meanwhile, there are
Jörg, Schubert, Michael, Dechant
openaire   +1 more source

Thrombotic microangiopathies

Critical Reviews in Oncology/Hematology, 1991
P, Ruggenenti, G, Remuzzi
openaire   +2 more sources

Thrombotic Microangiopathies

2021
Joseph J. Shatzel, Thomas G. DeLoughery
openaire   +1 more source

Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study.

The Lancet Haematology, 2017
Pavan K. Bendapudi   +16 more
semanticscholar   +1 more source

Thrombotic microangiopathies of pregnancy: Differential diagnosis.

Pregnancy Hypertension, 2018
Megha Gupta, B. Feinberg, R. Burwick
semanticscholar   +1 more source

A review of thrombotic microangiopathies in multiple myeloma.

Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis, 2019
A. Portuguese   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy